FIELD: organic chemistry, polymers, peptides, medicine, pharmacy. SUBSTANCE: invention relates to a polymeric conjugate synthesized by interaction of compounds of the formula (II): where one of A2 and A3 means chemical bond and other means A; R means phenyl or t-butoxy-group; R3 means hydrogen atom or acetyl-group; A means a simple chemical bond, an amino acid residue or peptide spacer taken from: β--Ala, Gly, Phe-Gly, Phe-Phe, Leu-Gly, Val-Ala, Phe-Ala, Leu-Phe, Leu-Ala, Phe-Leu-Gly, Phe-Phe-Leu, Leu-Leu-Gly, Phe-Tyr-Ala, Phe-Gly-Phe, Phe-Phe-Gly, Phe-Leu-Gly-Phe, Gly-Phe-Leu-Gly-Phe, Gly--β--Ala, Phe-Gly--β--Ala, Phe-Phe--β--Ala, Leu-Gly--β--Ala, Val-Ala--β--Ala, Phe-Ala--β--Ala, Leu-Phe--β--Ala, Leu-Gly--β--Ala, Leu-Leu-Gly--β--Ala, Phe-Tyr-Ala-β--Ala, Phe-Gly-Phe-β--Ala, Phe-Phe-Gly-β--Ala, Phe-Leu-Gly-Phe-β--Ala or Gly-Phe-Leu-Gly-Phe-β--Ala which are interacted with an activated polymer consisting of 90-90.9 mole% links of the formula:
and 10-0.1 mole% links of the formula:
. Process is carried out in an anhydrous polar solvent at 15-40 C for 1-24 h in the presence of an organic or inorganic base followed by treatment of obtained conjugate with 2-hydroxypropylamine. Invention relates to a pharmaceutical composition showing an antitumor activity and containing a polymeric conjugate as an active component taken at effective amount. EFFECT: improved solubility, decreased toxicity of synthesized compounds as compared with that of paclitaxel. 7 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
BIOLOGICALLY-ACTIVE POLYMER-BOUND ANTHRACYCLINES, INTERMEDIATES, PREPARATION METHODS, AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2145965C1 |
POLYMERIC CONJUGATE, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2149646C1 |
BINDING AGENT FOR BIOACTIVE PREPARATIONS, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS | 1991 |
|
RU2116087C1 |
AZAANTRACYCLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2159245C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTHRACYCLINE GLYCOSIDES BOUND WITH POLYMERIC DERIVATIVE | 1992 |
|
RU2118171C1 |
METHOD OF OBTAINING PEPTIDES | 0 |
|
SU639446A3 |
ANTIBODY-DRUG CONJUGATE | 2013 |
|
RU2776489C2 |
DERIVATIVES OF ANTHRACYCLINONE AND THEIR USE IN AMYLOIDOSIS | 1995 |
|
RU2167661C2 |
NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE | 2019 |
|
RU2809547C2 |
UREIDO-DERIVATIVES OF NAPHTHALENEPHOSPHONIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION ON SAID | 1995 |
|
RU2136692C1 |
Authors
Dates
1999-05-20—Published
1993-06-07—Filed